Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$2.41
-0.05-2.03%
Last update: Oct 12, 4:39 PM
$2.41
-0.05-2.03%
Ovid Therapeutics Inc (OVID) Stock Price, Quote, News & History
OVIDNASDAQ
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Ovid Therapeutics Inc is a biopharmaceutical company that is dedicated to reducing seizures and meaningfully improving the lives of people affected by rare epilepsies and seizure-related neurological disorders. The company has built a differentiated...
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Ovid Therapeutics (NASDAQ:OVID) through any online brokerage.
Other companies in Ovid Therapeutics’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Moderna Inc (NASDAQ:MRNA).
Ovid Therapeutics has a consensus price target of $4.75.
The stock price for Ovid Therapeutics (NASDAQ: OVID) is $2.41 last updated October 12, 2026 at 4:39 PM EDT.
There are no upcoming dividends for Ovid Therapeutics.
Ovid Therapeutics does not have any upcoming earnings scheduled.
There is no upcoming split for Ovid Therapeutics.
Ovid Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
